Description:Cedirogant (also known as ABBV-157) is a novel and orally active RORγt inverse agonist. Cedirogant can be used for psoriasis research.

References: Experimental Pharmacological Management of Psoriasis. PMID: 34345187 PMCID: PMC8323855 DOI: 10.2147/JEP.S265632

纯度：≥98%

CAS：2055496-11-0